- $215.21m
- $326.24m
- $446.55m
- 32
- 61
- 79
- 58
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 383 | 396 | 430 | 448 | 447 |
Cost of Revenue | |||||
Gross Profit | 150 | 160 | 160 | 154 | 143 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 370 | 384 | 422 | 445 | 446 |
Operating Profit | 12.5 | 12.3 | 8.15 | 2.38 | 0.504 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.69 | -4.56 | -2 | -6.79 | -11.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.83 | -6.31 | -5.35 | -9.28 | -15.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.83 | -6.31 | -5.35 | -9.28 | -15.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.83 | -6.31 | -5.35 | -9.28 | -15.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.042 | 0.002 | -0.058 | -0.079 | -0.141 |